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Abstract 
 
Introduction: Obesity is a top public health priority but interventions to reverse the condition have 
had limited success. About 1-in-3 obese adults are free of metabolic risk factor clustering and are 
considered ‘healthy', and much attention has focused on the implications of this state for obesity 
management.  
Areas covered: We searched for individual studies, systematic reviews, and meta-analyses which 
examined correlates and outcomes of metabolically healthy obesity. We discuss the key roles of fat 
distribution and physical activity in determining healthy vs. unhealthy obesity and report a greatly 
increased risk of incident type 2 diabetes associated with healthy obesity vs. healthy normal-weight, 
among other outcomes. We argue that despite inconsistencies in the definition, patterns across 
studies clearly show that healthy obesity is a state of intermediate disease risk.  
Expert commentary: Given the current state of population-level evidence, we conclude that obesity 
and metabolic dysfunction are inseparable and that healthy obesity is best viewed only as a state of 
relative health but not of absolute health. We recommend that weight loss through energy 
restriction be a stand-alone target in addition to increased physical activity for minimising risk of 
future disease.  
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1. The stubborn issue of obesity 
 
The global prevalence of obesity has tripled since the mid-1970s (1), with about 1-in-3 adults in the 
United States (2) and about 1-in-4 adults in the United Kingdom (3) now considered obese. These 
levels are concerning primarily because of the high burden of chronic disease linked with obesity; 
these most notably include type 2 diabetes, cardiovascular diseases, musculoskeletal disorders, 
depression, and several types of cancer (4), culminating in a reduced quality of life and an increased 
risk of early death (5, 6). Apart from personal strains placed on individuals and families affected, this 
high prevalence of obesity confers extortionate financial costs to health and social care systems, 
often running into the tens of billions per year (7).  
Most studies measure obesity using body mass index (BMI) which is an indirect measure of body fat 
expressed as a simple ratio of weight in kilograms over height in meters-squared. BMI does not 
distinguish fat from lean mass and does not describe how fat is distributed within the body, but it 
nevertheless remains a validated measure against dual-X-ray absorptiometry (DXA)-assessed 
adiposity for both men and women (8, 9) and a consistent predictor of real clinical outcomes 
including type 2 diabetes (10), cardiovascular disease (11), and premature mortality (5, 6), often to 
the same degree as more localised fat indicators. For example, a standard unit increase in each of 
BMI and waist circumference is associated with a near-doubling in risk of developing type 2 diabetes 
(12).  
Reversing the obesity epidemic has proven to be challenging. Given the extraordinarily wide range of 
proximal and distal factors which contribute to a positive energy balance (13, 14), it is perhaps not 
surprising that individual-level diet- and physical activity-based interventions aimed at tipping this 
balance tend initially to be moderately effective at reducing weight (15), but then tend to lose 
effectiveness over longer periods, resulting in weight-regain in most cases (16). The reality is that 
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once established, obesity is difficult to reverse – only about 1 in 100 obese adults and about 1 in 
1000 morbidly obese adults annually achieve a normal-weight (17). The stubbornness of obesity has 
motivated deeper investigations into what exactly makes it harmful for the sake of prioritising 
individual and public resources – if obesity cannot be reversed, can it at least be made harmless?  
 
2. A ‘healthy’ type of obesity 
 
The bulk of the disease burden associated with obesity is thought to be mediated through 
disruptions to metabolism (18), and so one novel way of studying obesity has been to separate one’s 
obesity status from one’s metabolic health status in order to examine whether metabolic 
functioning can be preserved despite being obese. Beyond this basic intention, ‘healthy’ obesity is a 
matter of definition. Most studies base their definition of health on the absence of metabolic risk 
factor clustering, using criteria such as that proposed by the US National Cholesterol Education 
Program (19) which requires no more than 2 of 6 risk factors to be present in defining health (high 
blood pressure, high blood glucose, high triglycerides, low HDL cholesterol, and high sex-specific 
waist circumference). Other criteria exclude waist circumference and additionally consider insulin 
resistance and systemic inflammation in a more stringent definition, requiring no more than 1 risk 
factor in defining health (20). Owing to high correlations between BMI and waist circumference (21), 
only one obesity indicator is best used at a time in such definitions of healthy obesity, given that 
most adults who are generally obese would also be centrally obese. When applying such criteria to 
representative samples of the general population a substantial proportion of obese adults, about 1-
in-3, are considered ‘healthy’ (20, 22). By the same method, a proportion of normal-weight adults 
can be considered ‘unhealthy’, showing a clustering of the same metabolic risk factors, although this 
is much less common than among obese adults (about 20% of normal-weight versus about 70% of 
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obese). In general, the higher the BMI group, the higher the likelihood of being classified as 
metabolically unhealthy.  Thus, for the purposes of this review, the term ‘healthy obesity’ will be 
used to refer to obesity that presents without metabolic dysfunction; criteria and cut-points vary by 
study.  
 
3. What explains healthy obesity?  
 
In asking what factors explain healthy obesity, recent research has focused on differences in 
underlying physiology. Studies using magnetic resonance imaging (MRI) and computerised 
tomography (CT) technologies have long-documented distinct typologies of fat stores and their links 
with metabolic functioning (23), making fat distribution a strong candidate in explaining relative 
health among the obese. A broad distinction is usually made between subcutaneous fat which is 
located peripherally in places such as arms and legs, and visceral fat which is located centrally in 
places such as the abdomen and around or within internal organs; the latter being more 
metabolically active and more concentrated with adipocytes which induce systemic inflammation 
(24), insulin resistance (25), and hyperglycaemia (26). A potential upstream determinant of fat 
distribution is the ability of subcutaneous fat cells to expand in response to a surplus of incoming 
triglycerides (27-29); this implies that some obese adults are better able to contain fat within 
relatively safe stores resulting in a healthy profile, while others are prone to having this fat ‘spill 
over’ into unsafe stores resulting in an unhealthy profile.     
Several population-based studies have reported a lower waist circumference among healthy than 
among unhealthy obese adults (20, 30) despite similar levels of BMI. More detailed assessments 
confirm lower volumes of visceral fat among the healthy versus the unhealthy obese, despite little-
to-no difference in subcutaneous fat between them (31-33). Healthy obese women have also shown 
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more subcutaneous fat in the thigh than unhealthy obese women (31), likely reflecting a gender-
biased pattern of fat storage. Others have gone further, demonstrating lower traces of fat in the 
liver among healthy than among unhealthy obese adults (34-36), which is strongly deterministic of 
insulin resistance (25). A recent experimental study demonstrated that adults who were initially 
unhealthy obese were more likely than those initially healthy obese to gain fat in visceral stores in 
response to an equal amount of diet-induced weight gain over a period of 2 weeks (37). This weight 
gain resulted in a worsened metabolic profile among the initially unhealthy obese, but not among 
the initially healthy obese, suggesting that a superior ability to store fat in relatively safe 
subcutaneous stores does indeed help to explain relative health among the obese.  
Looking beyond physical characteristics, we can look to a behaviour which is robustly associated with 
features of metabolic risk factor clustering – physical activity (18). Whether done for the purpose of 
sport or tasks of daily living, physical activity of at least a moderate intensity results in the 
contraction of skeletal muscle which is recognised to be an active endocrine organ that in turn 
stimulates the release of acute pro-inflammatory and chronic anti-inflammatory cytokines which 
together promote a robust immune system (38). Muscle contraction also improves sensitivity of 
muscle tissue to insulin and facilitates the absorption of glucose into muscle, which directly enables 
energy expenditure and maintenance of normal glucose levels in the blood (39); contraction also 
releases lipoprotein-enzyme complexes which break-down triglycerides in the blood and prevent 
their deposition into subcutaneous or visceral fat stores (40, 41). Additionally, the contraction of 
muscle is effective in maintaining normal resting levels of blood pressure, with meta-analyses of 
randomised controlled trials confirming this to be true in response to either resistance- or aerobic-
based physical activity (42, 43). When considering metabolic risk factors collectively, physical activity 
consistently reduces risk of their clustering among adults in large population-based samples (44, 45). 
Another key benefit of physical activity which extends beyond metabolism is for improving body-
wide utilisation of oxygen by way of increased cardiorespiratory fitness (46), for which associations 
with physical activity are dose-response in nature (47).  
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Physical activity levels tend to be higher among adults who are metabolically healthy versus 
unhealthy and among adults who are normal-weight versus obese (48, 49). Less is known about 
whether healthy obese adults are more physically active than their unhealthy obese counterparts. 
This seems intuitive, but several cross-sectional studies reported no difference in total physical 
activity between healthy and unhealthy obese groups (30, 33, 50), with differences in moderate-to-
vigorous physical activity being evident in only half (20, 33) of the studies which examined this (30, 
51). All of these studies utilised self-reported questionnaire-based measures of physical activity 
duration, which are known to have low-to-moderate correlations with objective accelerometer-
based activity measures (52), and for which measurement error may be highest among the obese 
due to inaccurate recall or social desirability biases (53). When examining differences in total 
physical activity between healthy and unhealthy obese adults using an accelerometer, we 
demonstrated that total physical activity was higher among healthy versus unhealthy adults of any 
BMI group, including the obese, with a clear graded pattern of less physical activity among more 
adverse metabolic and obesity combinations (54). One additional study reported slightly higher 
levels of cardiorespiratory fitness among healthy than among unhealthy obese adults, by about 0.5 
METs (55); this difference was apparent when using either body fat percentage or BMI to define 
obesity. Together, this suggests that higher physical activity and higher cardiorespiratory fitness do 
help explain a healthier metabolic profile among the obese; however these levels are only relatively 
higher, given that both physical activity and fitness are still much lower among healthy obese than 
among healthy normal-weight adults (54, 55). 
 
4. Is healthy obesity harmless?  
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In order to determine whether healthy obesity is harmless with respect to clinical outcomes, we 
must shift focus away from making comparisons between healthy and unhealthy obese adults, and 
begin to make comparisons between healthy obese and healthy normal-weight adults (the 
theoretically healthiest group). ‘Healthy’ is a matter of binary labelling based on clinical cut-points, 
and subtle differences in these metabolic risk factors may exist between obese and normal-weight 
adults who are both given this label, which would reveal important differences in subclinical disease 
burden. Studies which have examined differences in continuous levels of metabolic risk factors 
between healthy obese and healthy normal-weight adults report that blood lipids, blood pressure, 
and insulin resistance are indeed more adverse among the healthy obese (20, 36, 54, 55). Levels of 
coronary artery calcification have also been found to be higher among healthy obese than among 
healthy normal-weight adults (56), providing more direct evidence of subclinical cardiovascular 
disease burden; calcification was not higher in one additional study (36) but this lack of difference 
may be due to reliance on a restrictive sub-sample of healthy obese adults who were free of 
hypertension and type 2 diabetes, given that differences in calcification were mediated by such 
factors in the larger study (56).   
As mentioned, most studies consider obese adults to be healthy if they have less than 2 of 5 
metabolic risk factors, thus allowing for 1 metabolic risk factor to be present at baseline. When 
examining prevalence of healthy obesity using a stricter definition, allowing for 0 metabolic risk 
factors, about 1-in-10 obese adults are considered healthy (57, 58), down from about 1-in-3 when 
using the more lenient definition (58, 59), indicating that most healthy obese adults have 1 
metabolic risk factor to begin with (Figure 1). Studies tend to use more lenient definitions in order to 
follow traditional criteria for metabolic risk factor clustering, but this may also be for practical 
reasons as it affords a larger group and thus greater statistical power to associate this status with 
clinical outcomes; relying on a strict definition leaves very few healthy obese adults left to study.  
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Next, in order to determine whether healthy obesity is harmless, we must ask whether it is actually 
stable over time or whether it is a phase leading to unhealthy obesity. Through use of repeated 
measures of metabolic and obesity statuses on the same individuals over time, studies have shown 
that after 6 years of follow-up, about one-third of initially healthy obese adults had become 
unhealthy obese (30, 60); others report that after 7-10 years this proportion is nearly half (58, 61-
63); and after 20 years this figure is just over half (59). The proportion of healthy obese adults who 
progress to unhealthy obesity appears larger with longer follow-up periods, indicating that the 
tendency to progress gets stronger with time. When we compared tendencies for progression, 
adults who began as healthy obese were found to be nearly 8-times more likely to end-up as 
unhealthy obese after 20 years than those who began as healthy but were of a lower BMI, further 
positioning healthy obesity as a phase (59). This differential tendency for progression is illustrated in 
Figure 2. Furthermore, when using a strict definition of healthy obesity based 0 metabolic risk 
factors in a separate study (57), nearly 80% of these strictly healthy obese adults had developed at 
least 1 metabolic risk factor after 20 years (compared with 60% of strictly healthy normal-weight 
adults) indicating that a strictly healthy type of obesity is rarely maintained. The development of 
insulin resistance was largely responsible for declining metabolic health status among these strictly 
healthy obese adults throughout the follow-up period.   
We now turn attention to real clinical outcomes. Given strong links between obesity and incident 
type 2 diabetes (12), numerous studies have examined whether risk is also elevated for obese adults 
who are metabolically healthy. We summarised results of 8 studies in a meta-analysis (64), finding 
that healthy obese adults have about 4-times greater risk of incident type 2 diabetes compared with 
healthy normal-weight adults; excess risk being highest among the unhealthy obese at nearly 9-
times greater risk. Some heterogeneity in effect estimates for healthy obesity was observed across 
the 8 studies, but this referred only to the size of effect, not the directionality of effect. Effects also 
did not significantly differ by duration of follow-up, indicating that high excess risk for type 2 
diabetes is evident even over short periods of time. The magnitude and consistency of excess risk for 
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type 2 diabetes among healthy obese adults fits with what is known about progressions from 
healthy to unhealthy obesity, given strong links with future insulin resistance (57) which 
subsequently induces hyperglycaemia. Since this meta-analysis, at least 6 additional studies have 
examined type 2 diabetes risk among healthy obese versus healthy normal-weight adults, all of 
which report excess risk of a similar magnitude (65-70).  
Future risk for developing cardiovascular disease has also been widely compared between healthy 
obese and healthy normal-weight adults; to date, 2 meta-analyses have been published. The first of 
these, by Fan et al. (71), examined incident coronary heart disease or stroke across 8 studies and 
summarised risk of these events to be 1.5-times higher among healthy obese than among healthy 
normal-weight adults, this being greatest among unhealthy obese adults at about 2.9-times higher. 
Excess risk was higher within the 3 studies which used a follow-up duration greater than 15 years, at 
about 2-times higher risk, and lower but still significantly elevated within the 6 studies which used 
follow-up durations of 15 years or less, at about 1.4-times higher risk, suggesting that risk of 
developing cardiovascular disease among healthy obese adults gets higher with time. Patterns of 
results were expectedly similar in the second meta-analysis by Kramer et al. (72), albeit with less 
clarity over the outcome being examined, given that incident cardiovascular events were grouped 
together with all-cause and cardiovascular-related mortality as a single composite outcome. Still, the 
4 studies which used follow-up durations of at least 10 years showed about 1.2-times higher risk 
among healthy obese than among healthy normal-weight adults, and the events being examined in 
these 4 studies were in fact incident cardiovascular events, not mortality (73-76). Once again, excess 
risk among unhealthy obese adults was greatest, at about 2.6-times higher.  
Most studies to date have focused on the metabolic or cardiovascular outcomes of healthy obesity, 
but these are not the only important domains of health. For instance, given obesity’s strong link with 
development of kidney disease (6), several recent studies have examined whether this is also true of 
healthy obese adults. The risk for both incident kidney disease (77, 78) and of end-stage kidney 
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disease is reported to be higher among healthy obese than among healthy normal-weight adults (79) 
across 3 studies, excess risk again being greatest among unhealthy obese adults in line with patterns 
observed for type 2 diabetes and cardiovascular outcomes. Given established, albeit complicated, 
links between BMI and development of several types of common cancer (80, 81), it is also worth 
comparing these risks between healthy obese and healthy normal-weight adults; this has not been 
done, but a higher risk of cancer-related mortality among healthy obese than among healthy 
normal-weight adults has been reported in one study (55). Additionally, given the increased 
mechanical strain placed on joints by excess fat and strong links between higher BMI and 
development of osteoarthritis (11), a higher burden of musculoskeletal disorders may also be 
expected among obese adults who are metabolically healthy, but again, this has not yet been 
examined. We  have compared prevalence of depressive symptoms between healthy obese and 
healthy normal-weight adults by pooling results of 8 studies in a meta-analysis (82), finding healthy 
obese adults to have about 1.3-times higher risk for being depressed than healthy normal-weight 
adults; excess risk again being highest among unhealthy obese adults at about 1.6-times higher. 
Finally, looking beyond the development of disease to the risk of early death, a meta-analysis (71) 
reviewed 9 studies and summarised risk for death from all causes to be about 1.2-times higher 
among healthy obese than among healthy normal-weight adults. Excess risk of death due specifically 
to cardiovascular causes was nearly 1.4-times higher among the healthy obese based on 6 studies. 
As mentioned, healthy obese adults have also shown excess risk for death due to cancer, although 
based on a single study (55). 
Thus, when considering prospective evidence linking healthy obesity with a range of clinical 
outcomes, it becomes clear that healthy obesity is not really healthy in an absolute sense. Healthy 
obese adults tend to begin prospective studies with more adverse levels of individual metabolic risk 
factors than healthy normal-weight adults, and they are also far more likely to progress to unhealthy 
obesity. Healthy obese adults are consistently more likely than healthy normal-weight adults to 
develop a range of chronic diseases, the strongest and most consistent links being with development 
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of type 2 diabetes, supporting inseparable links between excess body fat and poor glucose control. 
These trends culminate in an increased risk of early death related to cardiovascular- and cancer-
related causes. For each outcome studied, it is also clear that healthy obesity is an intermediate 
state of risk; excess risk for disease is not as high as for unhealthy obesity, but is still higher than for 
healthy normal-weight. These patterns are illustrated in Figure 3. Indeed, despite widely varying 
definitions of healthy obesity used across studies, the patterns for incident disease are remarkably 
consistent; effect sizes do vary, but conclusions do not.  
 
5. What explains declining health among the initially healthy obese?  
 
Having observed strong tendencies for declining health and for future disease among initially healthy 
obese adults, it is worth addressing factors which may influence these outcomes. Studies typically 
account for a range of demographic and health-related factors when estimating risk, but a review of 
these factors may be best focused on fat distribution and physical activity given their strong links 
with metabolic health. How we address such factors depends on what role they are theorised to play 
in associations between healthy obesity and decline – whether as confounders, as mediators, or as 
effect modifiers (83).  
When examining the role of fat distribution in progressions from healthy to unhealthy obesity, at 
least 4 studies have reported that stability of a healthy obese status over time is linked with a lower 
waist circumference relative to healthy obese adults who progressed to ill-health (30, 58, 61, 62), 
indicating that maintaining a favourable fat distribution may protect against decline. One additional 
study reported that excess risk for type 2 diabetes among healthy obese adults was evident only 
among those who also had traces of fat in the liver (69), suggesting that fat distribution may modify 
type 2 diabetes risk. Muscle mass may also modify type 2 diabetes risk given insight from studies on 
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dynapenic obesity among older adults; these tend to show that obesity in combination with a low 
grip-strength confers greater risk for type 2 diabetes than either obesity or low grip-strength on its 
own (84), possibly due to effects of insulin resistance resulting from low muscle mass (85). 
Furthermore, 2 studies have shown that excess type 2 diabetes risk is not evident among healthy 
obese adults who maintain their healthy state over the duration of follow-up (30, 86); declining 
health status likely being an effect modifier due to its strong mediating role for disease 
development, with progressions to ill-health being an inherent part of the disease process.  
Adjustment for initial levels of physical activity in 2 studies examining progressions from healthy to 
unhealthy obesity found no evidence for confounding by physical activity (30, 58), while 1 study did 
(61), albeit while not separating obese adults from overweight adults in the comparison group. 
Adjustment for physical activity was made in 4 out of the 8 studies (64, 87-89) included in the meta-
analysis of incident type 2 diabetes (64), and this had minimal impact on effect estimates, with 
excess risk among healthy obese adults remaining significantly elevated in each study. Thus, excess 
risk for type 2 diabetes among healthy obese adults does not appear to be explained by differential 
engagement in physical activity. Results are less clear in relation to cardiovascular disease. 
Adjustment for physical activity was made in only 2 out of 8 studies (76, 90) included in a meta-
analysis of incident cardiovascular disease (71), but excess cardiovascular risk among healthy obese 
adults was absent before adjustment in both studies. Adjustment for cardiorespiratory fitness did 
attenuate associations between healthy obesity and incident cardiovascular events in one study 
(55); the same was apparent for cardiovascular-related mortality. Excess risk for cancer-related 
mortality among healthy obese adults remained evident after adjustment for fitness in the same 
study. 
When studies adjust for physical activity or fitness they assume that either factor acts as a simple 
confounder, such that differences in risk of the outcome between healthy obese and healthy 
normal-weight adults either partially or entirely reflect differences in physical activity or fitness. 
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They also assume that effects of physical activity or fitness are equal among exposure groups. If, 
however, there is evidence that physical activity mediates associations between healthy obesity and 
metabolic decline then it would not be appropriate to adjust for physical activity as it would lie on 
the causal pathway. Several prospective observational studies suggest that higher adiposity leads to 
inactivity and not vice versa (91, 92), and results from a recent study among children which 
examined genetically elevated BMI in relation to objectively measured physical activity using a 
Mendelian randomisation approach found evidence for a causal association between higher BMI and 
lower subsequent physical activity (93). This study is particularly valuable as it avoids issues of 
confounding and reverse causality which are inherent to observational epidemiology, given that 
robustly associated genetic variants which are assigned randomly and independently at conception 
are used as proxies for measured BMI (94, 95). Nevertheless, pleiotropic influences cannot be 
discounted. 
Whether physical activity or fitness modifies excess disease risk among healthy obese adults has not 
been specifically examined, however these effects may be inferred from previous work comparing 
risk among highly active or highly fit obese adults with similarly active or fit normal-weight adults, 
assuming that there are considerable overlaps with metabolic health statuses. In 2 such studies, 
obese adults who were highly active showed over 10-times greater risk for incident type 2 diabetes 
than normal-weight adults who were similarly active (96, 97); another study reported that obese 
adults who were highly fit carried 3-times higher risk for incident type 2 diabetes than normal-
weight adults who were also highly fit (98). A systematic review later confirmed these trends for 
impaired glucose control and type 2 diabetes, additionally concluding that excess risk among highly 
active or fit obese adults is even higher than among normal-weight adults who are inactive or unfit 
(99). Patterns of risk appear similar for cardiovascular outcomes, with physically active obese adults 
showing higher risk for cardiovascular events than physically active normal-weight adults in 4 studies 
(100-103), this excess risk being nearly 3-times higher in half of these (102, 103).  
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A single baseline measure of physical activity is not likely sufficient to truly stratify risk groups, given 
that this behaviour is subject to considerable change over the duration of follow-up. Ideally, incident 
disease risk would be examined separately among healthy obese adults who maintain high levels of 
physical activity over the duration of follow-up and among those who do not maintain high levels 
based on repeated activity measures, but this is often not feasible given that such repeated 
measures may not be available and that few healthy obese individuals would exist in each stratified 
group, reducing the statistical power needed to detect meaningful differences. In such cases where 
high physical activity is maintained, ‘obesity’ likely refers to a high muscle and subcutaneous fat 
mass with minimal visceral fat (104). Randomised controlled trials using strictly supervised physical 
activity regimes have shown these to be effective at reducing abdominal and visceral fat even in the 
absence of total weight loss (104-106); these reductions improve glucose control and may in turn 
minimise disease risks. However, given other studies reviewed which suggest that physical activity 
does not eliminate excess risk for eventual disease among obese adults, a key issue here is likely the 
maintenance of such physical activity over time which is notoriously low among obese adults (107). 
Physical activity is only expected to be protective for as long as it is maintained and if maintenance is 
less likely among obese than among normal-weight adults then even an obesity paired with high 
physical activity would still be considered a high risk state for future decline. An important but 
unanswered question is once habitual physical activity ceases, whether the likelihood of progressing 
to metabolic ill-health is greater the higher the underlying BMI. 
Observations that some excess risk for disease remains among obese adults who are metabolically 
healthy or who are physically active or fit suggest that there are inherent links between excess body 
fat and metabolic dysfunction. Such links are supported by at least 2 large Mendelian randomisation 
studies which recently examined causal effects of genetically elevated BMI on a range of metabolic 
risk factors, many of which are commonly used to define health among the obese. One of these 
studies, by Holmes et al. (108), reported causal effects of genetically elevated BMI on higher levels of 
fasting glucose, insulin, systemic inflammation, and blood pressure, with mixed results for blood 
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lipids. Genetically elevated BMI also showed a clear causal effect on type 2 diabetes development, at 
about 1.3-times higher risk per unit increase in the BMI genetic risk score; this was not evident for 
coronary heart disease or stroke (108). A second study, by Würtz et al. (109), reported adverse 
causal effects of genetically elevated BMI on blood-based metabolites of lipoproteins, lipids, fatty 
acids, and glucose among others, based on a large sample of young adults whose BMI was below the 
obese range. Effect sizes were larger among those who had gained weight over 6 years (109). Thus, 
the main reason why obese adults who are relatively healthy or physically active still tend to 
experience metabolic decline, is likely that obesity is itself causing this decline. Obesity and 
metabolic dysfunction are truly inseparable. 
 
6. Does weight loss benefit healthy obese adults? 
 
Given known excess risk for a range of diseases among healthy obese adults, it follows that weight 
loss should be recommended in order to reduce these risks; but is there evidence that this works?  
When considering all obese adults collectively, significant metabolic benefits are known to occur 
with as little as 5% weight loss, with the magnitude of these benefits being progressively greater for 
weight loss of 10% and 15% (110). Several studies have compared these benefits between obese 
adults who were initially healthy versus those who were initially unhealthy, and at face value, results 
appear to be mixed. For example, in response to an intervention based entirely on energy 
restriction, one 12-week study reported improvements to systemic inflammation and to a range of 
blood lipids among initially unhealthy obese but not among initially healthy obese adults (111); 
insulin resistance decreased in both groups although not at a significant level. Another 6-month 
energy restriction-based intervention reported improved insulin sensitivity among the initially 
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unhealthy obese, but worsened insulin sensitivity among the initially healthy obese (112), albeit 
while not measuring other metabolic risk factors.  
Interventions which involve physical activity tend to report more positive results. One 6-month study 
involving an intervention based only on physical activity reported that initially healthy obese adults 
reduced insulin secretion and blood glucose concentrations while also increasing cardiorespiratory 
fitness relative to similarly healthy obese controls (113), this was in addition to reduced total body 
weight, BMI, and waist circumference. Two additional studies reported on interventions which 
combined energy restriction with physical activity, the first of which spanned 6 months and found 
improved insulin sensitivity among both initially unhealthy and initially healthy obese adults in 
addition to reduced total, subcutaneous, and visceral fat mass, and preserved muscle mass (114). 
The second 9-month intervention reported reductions in total and visceral fat mass in both groups 
but increased insulin sensitivity among obese adults who were initially unhealthy only (115).  
Greater improvements in metabolic risk factors would be expected among those obese adults who 
began as unhealthy, given that they had more room to improve. Unhealthy obese adults are also 
expected to begin interventions with higher volumes of visceral fat than the healthy obese, higher 
levels indeed being reported in studies which measured this at baseline (111, 114, 115). Given that 
healthy obese adults have less potential to increase insulin sensitivity by way of reducing visceral fat, 
mechanisms related to physical activity may be more effective. Clear benefits to body composition 
are observed for both initially healthy and unhealthy obese adults in response to interventions 
which involve physical activity as these can preserve or increase muscle mass and stimulate muscle 
contraction, which together can result in improved insulin sensitivity and a greatly reduced risk for 
future type 2 diabetes.  However, the greatest long-term benefits may still be expected with 
increased physical activity in combination with energy restriction to reduce BMI to at least below the 
obese range, as such high BMI may be a barrier to maintaining physical activity over time.  
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7. Concluding remarks 
 
The idea of a ‘healthy’ type of obesity is based on the observation that a sizable minority of obese 
adults, about 1-in-3, present without a clustering of metabolic risk factors. This state is likely 
explained through a favourable fat distribution by way of higher volumes of subcutaneous relative to 
visceral fat, and a favourable behavioural profile by way of higher physical activity, among other 
factors. When examining how these individuals change over time, however, prospective evidence 
has revealed that ‘healthy obesity’ is a highly misleading term as this state very often progresses into 
unhealthy obesity through incidence of metabolic risk factors, and very often results in the 
development of several types of disease. Excess risk is strongest and most consistent for 
development of type 2 diabetes, supporting inseparable links between obesity and poor glucose 
control. Other evidence suggests that excess risk for type 2 diabetes among obese adults remains 
elevated even among those who are physically active or fit, although these factors may reduce the 
magnitude of excess risk. These patterns of disease risk are remarkably consistent despite widely 
varying definitions of healthy obesity used in literature. For virtually every disease outcome 
examined healthy obesity is merely a state of intermediate risk; excess risk is not as high as for 
unhealthy obesity, but it is still higher than for healthy normal-weight. Healthy obesity is therefore 
best viewed only as a state of relative health but not of absolute health; it is better than unhealthy 
obesity but it is still not safe or harmless. Weight loss through energy restriction should therefore be 
a stand-alone target in addition to increased physical activity for minimising risk of future disease.  
 
8. Expert commentary 
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Obesity is very difficult to reverse. In light of this, the idea that obesity can exist without conferring 
metabolic dysfunction is highly attractive as this implies that these individuals are protected against 
future disease. Recent evidence has all but dismissed this idea. Although it is true that a sizable 
minority of obese adults are free of metabolic risk factor clustering and are considered ‘healthy’, 
when followed-up over time, these individuals demonstrate a strong tendency to progress to 
unhealthy obesity and to develop numerous chronic diseases including type 2 diabetes and 
cardiovascular disease. These outcomes occur at rates greater than among normal-weight adults 
who are similarly healthy and are not entirely explained by a lack of physical activity. New studies 
which utilise common genetic variants as proxies for body mass index have suggested that it is 
obesity itself which causes harm, and such evidence will likely continue to improve knowledge of 
causal links between obesity, low physical activity, and metabolic dysfunction in the future. Overall, 
the current state of population-level evidence strongly suggests that obesity and metabolic 
dysfunction are inseparable and that so-called healthy obesity is healthy only in a relative sense but 
not an absolute sense. The recommendation for public health is therefore to set weight loss through 
energy restriction as a stand-alone target in addition to regular physical activity for minimising risk of 
future disease.  
 
9. Five year view 
 
The topic of healthy obesity has progressed immensely in a short time. Five years ago, the 
recognition of a metabolically healthy type of obesity was thought to represent a paradigm shift in 
disease aetiology with obesity viewed as a separate entity from metabolic ill-health; these entities 
are now viewed as inseparable. This shift in understanding came from prospective evidence on how 
healthy obese adults change over time and how their risk of future disease differs from similarly 
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healthy normal-weight adults. Evidence on causal links between genetically elevated body mass 
index and subsequent low physical activity and metabolic dysfunction has also been valuable. In the 
next five years, such prospective and genetically informed evidence will likely continue to provide 
insight into disease outcomes of obesity which are beyond the traditional cardio-metabolic domain 
in order to better quantify obesity’s total impact on quality of life. Researchers and public health 
practitioners will likely gain a greater appreciation for the continuous nature of chronic disease risk 
which is better represented by a spectrum than by clinical cut-points. Long-term randomised 
controlled trials on the combined protective effects of maintaining high physical activity and a low 
energy/high nutrient diet from minimally processed food sources on risk of future disease among 
adults of different body mass indexes will be informative, as will be studies using genetic variants as 
proxies for risk factors in cases where such trials are not feasible. Lastly and importantly, it is hoped 
that a focus on the main systemic driver of weight gain in populations will be intensified through 
government action on improving the quality of the food supply.  
 
10. Key issues 
 
• At any given time, about 1-in-3 obese adults are free of metabolic risk factor clustering and are 
considered ‘healthy’. This healthy obese state is likely induced through lower visceral relative to 
subcutaneous fat and through higher physical activity relative to the unhealthy obese state. 
• Despite both groups falling below clinical cut-points for defining ‘metabolic ill-health’, healthy 
obese adults show more adverse levels of metabolic risk factors than similarly healthy normal-
weight adults. Healthy obese adults are also far more likely than healthy non-obese adults to 
progress to unhealthy obesity over time; this is likely driven by insulin resistance. 
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• Compared with healthy normal-weight adults, healthy obese adults are about 4-times more 
likely to develop type 2 diabetes, 1.2-times more likely to develop cardiovascular disease, and 
1.4-times more likely to die from cardiovascular-related causes. Excess risk is also evident for 
other outcomes including chronic kidney disease and death from cancer.    
• Low physical activity does not fully explain excess risk for type 2 diabetes among healthy obese 
versus healthy normal-weight adults, with excess risk remaining elevated among physically 
active obese adults versus similarly active normal-weight adults. Together with known causal 
associations of genetically elevated body mass index on low physical activity and metabolic risk 
factors, this strongly suggests that obesity and metabolic dysfunction are inseparable.   
• Overall, despite inconsistencies in the definition, consistent patterns across studies for a range 
of clinical outcomes reveal that healthy obesity is a state of intermediate risk; excess risk for 
disease is not as high as for unhealthy obesity but is still higher than for healthy normal-weight. 
Healthy obesity is therefore only a state of relative health, not absolute health.  
• Weight loss through energy restriction should be a stand-alone target in addition to increased 
physical activity for minimising risk of future disease. 
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Reference annotations 
 
5 and 6 * - Large high quality studies examining body mass index and mortality risk based on 
individual-level data 
11 * - Comprehensive review on risk of incident diseases associated with obesity 
12 * - Meta-analysis comparing the magnitude of effects of general and abdominal obesity indicators 
for incident type 2 diabetes  
20 ** - Study based on US NHANES data used to quote the prevalence of healthy obesity in the 
general population   
25 * - Extensive review on the physiological differences between subcutaneous and visceral fat 
tissue 
28 and 29 * - Intervention studies proposing the adipose tissue expandability hypothesis  
35 * - Review of healthy obesity focusing on implications for clinical practice 
37 * - Intervention study showing different metabolic effects of weight gain among initially healthy 
and unhealthy obese adults, reinforcing the adipose tissue expandability hypothesis 
38 * - Theoretical review of the protective effects of muscle contraction against fat tissue  
54 * - Study comparing objectively assessed physical activity levels across metabolic and obesity 
groups 
59 ** - Study examining progressions from healthy to unhealthy obesity over 20 years 
64 ** - Meta-analysis of healthy obesity and incident type 2 diabetes 
29 
 
69 ** - Study examining the modifying effect of liver fat in risk of type 2 diabetes among healthy 
obese adults 
71 ** - Meta-analysis of healthy obesity and risk of incident cardiovascular disease and mortality as 
separate outcomes 
83 * - Explanation of physical activity as a confounder, mediator, or effect modifier 
93 ** - Study examining the causal association between genetically elevated body mass index and 
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to examine causality 
108 and 109 ** - Studies examining causal associations between genetically elevated body mass 
index and metabolic risk factors 
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Figure 1 Proportion of obese adults who are considered healthy based on common and strict 
definitions of metabolic health 
 
Legend Data for Whitehall II Study are from Bell et al., 2015, J Am Coll Cardiol and Bell et al., 2015 
(2), J Am Coll Cardiol; Data for English Longitudinal Study of Ageing are from Hamer et al., 2015, Eur J 
Endocrinol
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Figure 2 Progressions to unhealthy obesity over 2 decades among non-obese and obese adults who 
are initially healthy 
  
Legend Data are from Bell et al., 2015, J Am Coll Cardiol, based on 1677 initially healthy non-obese 
adults and 66 initially healthy obese adults followed-up over 20 years
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Figure 3 Clinical outcomes of healthy obesity established through meta-analyses 
 
Data are summary relative risks from meta-analyses which are multivariable-adjusted when possible; incident type 2 diabetes based on Bell et al. 2014, 
Obes Rev; incident cardiovascular disease, death from all causes and death from cardiovascular causes based on Fan et al. 2013, Int J Cardiol.  
